pathology_id stringlengths 19 19 | country stringclasses 7
values | year int64 2.02k 2.03k | facility_type stringclasses 3
values | cancer_type stringclasses 10
values | icd_o_morphology_code stringclasses 9
values | morphology_description stringclasses 9
values | grade stringclasses 4
values | lymphovascular_invasion stringclasses 3
values | perineural_invasion stringclasses 3
values | margin_status stringclasses 4
values | ihc_er stringclasses 3
values | ihc_pr stringclasses 3
values | ihc_her2 stringclasses 4
values | ihc_ki67_index stringclasses 825
values | ihc_p53 stringclasses 3
values | molecular_subtype stringclasses 4
values | specimen_type stringclasses 4
values | diagnosis_confirmed stringclasses 3
values | turnaround_time_days int64 3 27 | scenario stringclasses 1
value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PATH-SOU-2022-04001 | South Africa | 2,022 | National referral | Colorectal | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Present | Not documented | Negative | Negative | Negative | Positive | 17.0 | Negative | null | Excisional biopsy | Yes | 27 | moderate_burden |
PATH-GHA-2021-04002 | Ghana | 2,021 | National referral | Breast | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Absent | Negative | Negative | Not done | Equivocal | 36.0 | Negative | Luminal A | Excisional biopsy | No - suboptimal | 9 | moderate_burden |
PATH-KEN-2025-04003 | Kenya | 2,025 | Regional | Prostate | 8720/3 | Melanoma | Poorly differentiated | Absent | Absent | Negative | Not done | Negative | Positive | 14.0 | Positive | null | Resection | Yes | 11 | moderate_burden |
PATH-SOU-2022-04004 | South Africa | 2,022 | District | Ovary | 8310/3 | Clear cell carcinoma | Poorly differentiated | Absent | Present | Negative | Not done | Negative | Negative | Not done | Positive | null | Excisional biopsy | No - inconclusive | 15 | moderate_burden |
PATH-KEN-2023-04005 | Kenya | 2,023 | District | Lung | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Present | Negative | Not done | Negative | Not done | Not done | Negative | null | Core needle biopsy | Yes | 13 | moderate_burden |
PATH-TAN-2025-04006 | Tanzania | 2,025 | National referral | Cervix | 8140/3 | Adenocarcinoma | Moderately differentiated | Not documented | Not documented | Close | Not done | Negative | Negative | Not done | Negative | null | Core needle biopsy | Yes | 6 | moderate_burden |
PATH-ETH-2020-04007 | Ethiopia | 2,020 | Regional | Prostate | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Present | Absent | Negative | Positive | Positive | Negative | 5.2 | Negative | null | Core needle biopsy | Yes | 18 | moderate_burden |
PATH-SOU-2022-04008 | South Africa | 2,022 | Regional | Bladder | 8310/3 | Clear cell carcinoma | Undifferentiated | Absent | Absent | Close | Negative | Negative | Negative | 15.7 | Positive | null | Excisional biopsy | Yes | 20 | moderate_burden |
PATH-SOU-2020-04009 | South Africa | 2,020 | District | Thyroid | 8510/3 | Medullary carcinoma | Well differentiated | Absent | Absent | Negative | Negative | Negative | Negative | Not done | Positive | null | Excisional biopsy | Yes | 25 | moderate_burden |
PATH-NIG-2021-04010 | Nigeria | 2,021 | Regional | Ovary | 8140/3 | Adenocarcinoma | Well differentiated | Absent | Absent | Positive | Positive | Positive | Negative | 34.5 | Negative | null | Resection | Yes | 16 | moderate_burden |
PATH-UGA-2023-04011 | Uganda | 2,023 | District | Prostate | 8510/3 | Medullary carcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Positive | Not done | Not done | Positive | null | Excisional biopsy | Yes | 18 | moderate_burden |
PATH-SOU-2019-04012 | South Africa | 2,019 | Regional | Colorectal | 8140/3 | Adenocarcinoma | Poorly differentiated | Not documented | Absent | Negative | Negative | Positive | Negative | 13.3 | Not done | null | Core needle biopsy | Yes | 17 | moderate_burden |
PATH-GHA-2023-04013 | Ghana | 2,023 | Regional | Colorectal | 8510/3 | Medullary carcinoma | Poorly differentiated | Absent | Present | Negative | Negative | Negative | Negative | Not done | Not done | null | Resection | Yes | 9 | moderate_burden |
PATH-SOU-2020-04014 | South Africa | 2,020 | District | Colorectal | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Not documented | Positive | Negative | Positive | Negative | Not done | Positive | null | Excisional biopsy | Yes | 9 | moderate_burden |
PATH-ETH-2024-04015 | Ethiopia | 2,024 | Regional | Thyroid | 8140/3 | Adenocarcinoma | Poorly differentiated | Not documented | Absent | Negative | Negative | Negative | Positive | 21.9 | Positive | null | Resection | Yes | 8 | moderate_burden |
PATH-TAN-2022-04016 | Tanzania | 2,022 | District | Liver | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Not documented | Close | Not done | Positive | Not done | Not done | Negative | null | Core needle biopsy | Yes | 7 | moderate_burden |
PATH-GHA-2025-04017 | Ghana | 2,025 | District | Prostate | 8260/3 | Papillary carcinoma | Moderately differentiated | Absent | Not documented | Not applicable | Positive | Positive | Negative | Not done | Not done | null | Excisional biopsy | Yes | 16 | moderate_burden |
PATH-KEN-2024-04018 | Kenya | 2,024 | National referral | Liver | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Present | Negative | Positive | Positive | Negative | 54.3 | Negative | null | Excisional biopsy | Yes | 26 | moderate_burden |
PATH-SOU-2018-04019 | South Africa | 2,018 | District | Thyroid | 8310/3 | Clear cell carcinoma | Moderately differentiated | Not documented | Absent | Negative | Negative | Positive | Negative | Not done | Positive | null | Core needle biopsy | Yes | 27 | moderate_burden |
PATH-KEN-2022-04020 | Kenya | 2,022 | District | Bladder | 8070/3 | Squamous cell carcinoma | Well differentiated | Present | Present | Not applicable | Negative | Positive | Positive | Not done | Negative | null | Core needle biopsy | No - inconclusive | 22 | moderate_burden |
PATH-SOU-2023-04021 | South Africa | 2,023 | District | Lung | 8310/3 | Clear cell carcinoma | Moderately differentiated | Present | Present | Negative | Negative | Positive | Negative | Not done | Negative | null | Excisional biopsy | Yes | 3 | moderate_burden |
PATH-ETH-2025-04022 | Ethiopia | 2,025 | District | Thyroid | 8430/3 | Mucoepidermoid carcinoma | Poorly differentiated | Absent | Absent | Close | Negative | Positive | Negative | Not done | Positive | null | Core needle biopsy | Yes | 18 | moderate_burden |
PATH-TAN-2022-04023 | Tanzania | 2,022 | Regional | Lung | 8430/3 | Mucoepidermoid carcinoma | Well differentiated | Not documented | Present | Negative | Positive | Positive | Negative | 88.1 | Not done | null | Fine needle aspirate | Yes | 18 | moderate_burden |
PATH-SOU-2019-04024 | South Africa | 2,019 | National referral | Prostate | 8070/3 | Squamous cell carcinoma | Undifferentiated | Present | Absent | Positive | Negative | Positive | Negative | Not done | Negative | null | Core needle biopsy | Yes | 10 | moderate_burden |
PATH-NIG-2019-04025 | Nigeria | 2,019 | National referral | Liver | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Present | Absent | Positive | Negative | Negative | Negative | 42.3 | Negative | null | Resection | Yes | 4 | moderate_burden |
PATH-TAN-2025-04026 | Tanzania | 2,025 | Regional | Lung | 8070/3 | Squamous cell carcinoma | Undifferentiated | Not documented | Absent | Positive | Positive | Negative | Negative | 9.6 | Negative | null | Core needle biopsy | Yes | 17 | moderate_burden |
PATH-KEN-2022-04027 | Kenya | 2,022 | Regional | Bladder | 8430/3 | Mucoepidermoid carcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Negative | Negative | 6.1 | Negative | null | Core needle biopsy | Yes | 22 | moderate_burden |
PATH-KEN-2025-04028 | Kenya | 2,025 | District | Lung | 8500/3 | Ductal carcinoma | Undifferentiated | Absent | Absent | Negative | Negative | Not done | Positive | Not done | Positive | null | Resection | Yes | 13 | moderate_burden |
PATH-KEN-2018-04029 | Kenya | 2,018 | District | Lung | 8140/3 | Adenocarcinoma | Poorly differentiated | Not documented | Absent | Negative | Positive | Positive | Negative | Not done | Negative | null | Core needle biopsy | Yes | 21 | moderate_burden |
PATH-GHA-2020-04030 | Ghana | 2,020 | District | Cervix | 8070/3 | Squamous cell carcinoma | Well differentiated | Present | Present | Negative | Positive | Positive | Not done | Not done | Not done | null | Core needle biopsy | Yes | 18 | moderate_burden |
PATH-ETH-2022-04031 | Ethiopia | 2,022 | District | Breast | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Not documented | Negative | Positive | Negative | Negative | Not done | Negative | Luminal A | Core needle biopsy | Yes | 26 | moderate_burden |
PATH-ETH-2018-04032 | Ethiopia | 2,018 | Regional | Breast | 8500/3 | Ductal carcinoma | Undifferentiated | Absent | Absent | Negative | Not done | Positive | Positive | 18.9 | Positive | Luminal A | Core needle biopsy | Yes | 14 | moderate_burden |
PATH-TAN-2021-04033 | Tanzania | 2,021 | Regional | Lung | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Present | Negative | Positive | Positive | Equivocal | 70.7 | Positive | null | Excisional biopsy | Yes | 19 | moderate_burden |
PATH-SOU-2020-04034 | South Africa | 2,020 | District | Ovary | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Present | Negative | Positive | Positive | Negative | Not done | Positive | null | Fine needle aspirate | No - suboptimal | 21 | moderate_burden |
PATH-SOU-2021-04035 | South Africa | 2,021 | Regional | Stomach | 8430/3 | Mucoepidermoid carcinoma | Undifferentiated | Absent | Present | Negative | Negative | Not done | Negative | 28.0 | Negative | null | Fine needle aspirate | No - inconclusive | 18 | moderate_burden |
PATH-TAN-2024-04036 | Tanzania | 2,024 | National referral | Prostate | 8720/3 | Melanoma | Poorly differentiated | Absent | Absent | Negative | Negative | Positive | Negative | 14.9 | Negative | null | Core needle biopsy | Yes | 11 | moderate_burden |
PATH-KEN-2019-04037 | Kenya | 2,019 | National referral | Cervix | 8500/3 | Ductal carcinoma | Poorly differentiated | Absent | Absent | Close | Negative | Not done | Equivocal | 62.8 | Positive | null | Core needle biopsy | Yes | 27 | moderate_burden |
PATH-ETH-2020-04038 | Ethiopia | 2,020 | National referral | Liver | 8070/3 | Squamous cell carcinoma | Well differentiated | Present | Present | Negative | Negative | Not done | Negative | 35.6 | Negative | null | Core needle biopsy | Yes | 24 | moderate_burden |
PATH-NIG-2024-04039 | Nigeria | 2,024 | National referral | Stomach | 8140/3 | Adenocarcinoma | Poorly differentiated | Not documented | Present | Negative | Positive | Negative | Negative | 66.2 | Positive | null | Resection | Yes | 5 | moderate_burden |
PATH-ETH-2020-04040 | Ethiopia | 2,020 | Regional | Thyroid | 8890/3 | Leiomyosarcoma | Moderately differentiated | Not documented | Not documented | Not applicable | Positive | Negative | Positive | 75.2 | Not done | null | Core needle biopsy | No - inconclusive | 3 | moderate_burden |
PATH-ETH-2021-04041 | Ethiopia | 2,021 | District | Thyroid | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Absent | Negative | Not done | Positive | Negative | 75.2 | Not done | null | Excisional biopsy | Yes | 11 | moderate_burden |
PATH-TAN-2018-04042 | Tanzania | 2,018 | District | Prostate | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Positive | Equivocal | Not done | Negative | null | Excisional biopsy | Yes | 12 | moderate_burden |
PATH-UGA-2025-04043 | Uganda | 2,025 | National referral | Bladder | 8890/3 | Leiomyosarcoma | Poorly differentiated | Present | Absent | Not applicable | Positive | Positive | Negative | 24.8 | Positive | null | Core needle biopsy | No - suboptimal | 23 | moderate_burden |
PATH-ETH-2025-04044 | Ethiopia | 2,025 | District | Liver | 8500/3 | Ductal carcinoma | Moderately differentiated | Present | Not documented | Positive | Negative | Not done | Negative | Not done | Negative | null | Excisional biopsy | Yes | 5 | moderate_burden |
PATH-ETH-2025-04045 | Ethiopia | 2,025 | National referral | Stomach | 8430/3 | Mucoepidermoid carcinoma | Undifferentiated | Not documented | Present | Not applicable | Negative | Negative | Negative | 54.5 | Negative | null | Core needle biopsy | Yes | 25 | moderate_burden |
PATH-ETH-2025-04046 | Ethiopia | 2,025 | Regional | Lung | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Present | Not documented | Close | Positive | Positive | Negative | 18.0 | Positive | null | Fine needle aspirate | Yes | 12 | moderate_burden |
PATH-SOU-2022-04047 | South Africa | 2,022 | District | Liver | 8500/3 | Ductal carcinoma | Well differentiated | Present | Not documented | Negative | Negative | Negative | Negative | Not done | Negative | null | Excisional biopsy | Yes | 9 | moderate_burden |
PATH-SOU-2025-04048 | South Africa | 2,025 | District | Lung | 8070/3 | Squamous cell carcinoma | Undifferentiated | Absent | Not documented | Negative | Negative | Positive | Negative | 84.1 | Negative | null | Core needle biopsy | Yes | 14 | moderate_burden |
PATH-NIG-2020-04049 | Nigeria | 2,020 | District | Colorectal | 8500/3 | Ductal carcinoma | Moderately differentiated | Absent | Absent | Positive | Positive | Negative | Negative | Not done | Positive | null | Excisional biopsy | Yes | 7 | moderate_burden |
PATH-TAN-2019-04050 | Tanzania | 2,019 | Regional | Bladder | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Not done | Positive | 65.4 | Positive | null | Fine needle aspirate | Yes | 7 | moderate_burden |
PATH-UGA-2024-04051 | Uganda | 2,024 | District | Cervix | 8500/3 | Ductal carcinoma | Moderately differentiated | Absent | Absent | Negative | Positive | Negative | Negative | Not done | Positive | null | Resection | Yes | 16 | moderate_burden |
PATH-NIG-2024-04052 | Nigeria | 2,024 | Regional | Lung | 8500/3 | Ductal carcinoma | Poorly differentiated | Present | Present | Negative | Negative | Negative | Negative | Not done | Not done | null | Core needle biopsy | Yes | 11 | moderate_burden |
PATH-SOU-2022-04053 | South Africa | 2,022 | National referral | Colorectal | 8510/3 | Medullary carcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Negative | Negative | 47.3 | Negative | null | Fine needle aspirate | Yes | 26 | moderate_burden |
PATH-ETH-2019-04054 | Ethiopia | 2,019 | National referral | Lung | 8140/3 | Adenocarcinoma | Undifferentiated | Present | Present | Negative | Negative | Negative | Negative | 69.2 | Negative | null | Excisional biopsy | Yes | 23 | moderate_burden |
PATH-GHA-2021-04055 | Ghana | 2,021 | Regional | Cervix | 8500/3 | Ductal carcinoma | Well differentiated | Absent | Absent | Positive | Negative | Negative | Negative | 71.7 | Not done | null | Resection | Yes | 10 | moderate_burden |
PATH-GHA-2019-04056 | Ghana | 2,019 | Regional | Cervix | 8430/3 | Mucoepidermoid carcinoma | Poorly differentiated | Absent | Present | Close | Not done | Positive | Negative | Not done | Positive | null | Resection | No - inconclusive | 3 | moderate_burden |
PATH-SOU-2022-04057 | South Africa | 2,022 | Regional | Cervix | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Negative | Negative | Negative | Negative | Not done | Negative | null | Excisional biopsy | Yes | 12 | moderate_burden |
PATH-NIG-2020-04058 | Nigeria | 2,020 | District | Bladder | 8070/3 | Squamous cell carcinoma | Well differentiated | Present | Not documented | Negative | Positive | Positive | Negative | Not done | Negative | null | Excisional biopsy | Yes | 9 | moderate_burden |
PATH-SOU-2022-04059 | South Africa | 2,022 | Regional | Thyroid | 8140/3 | Adenocarcinoma | Undifferentiated | Not documented | Absent | Not applicable | Negative | Positive | Positive | Not done | Negative | null | Fine needle aspirate | Yes | 10 | moderate_burden |
PATH-TAN-2021-04060 | Tanzania | 2,021 | National referral | Prostate | 8890/3 | Leiomyosarcoma | Moderately differentiated | Present | Not documented | Negative | Negative | Positive | Negative | 15.5 | Negative | null | Core needle biopsy | Yes | 12 | moderate_burden |
PATH-TAN-2021-04061 | Tanzania | 2,021 | Regional | Thyroid | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Not documented | Present | Negative | Negative | Positive | Negative | Not done | Positive | null | Core needle biopsy | Yes | 22 | moderate_burden |
PATH-ETH-2020-04062 | Ethiopia | 2,020 | Regional | Ovary | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Absent | Negative | Positive | Positive | Negative | Not done | Not done | null | Core needle biopsy | Yes | 23 | moderate_burden |
PATH-TAN-2025-04063 | Tanzania | 2,025 | National referral | Thyroid | 8140/3 | Adenocarcinoma | Well differentiated | Absent | Absent | Negative | Positive | Positive | Positive | 28.7 | Negative | null | Fine needle aspirate | Yes | 26 | moderate_burden |
PATH-TAN-2018-04064 | Tanzania | 2,018 | National referral | Prostate | 8430/3 | Mucoepidermoid carcinoma | Undifferentiated | Not documented | Present | Negative | Negative | Negative | Negative | 5.7 | Positive | null | Excisional biopsy | Yes | 22 | moderate_burden |
PATH-KEN-2020-04065 | Kenya | 2,020 | Regional | Bladder | 8430/3 | Mucoepidermoid carcinoma | Undifferentiated | Absent | Absent | Negative | Positive | Negative | Negative | Not done | Positive | null | Core needle biopsy | Yes | 12 | moderate_burden |
PATH-SOU-2020-04066 | South Africa | 2,020 | National referral | Liver | 8500/3 | Ductal carcinoma | Moderately differentiated | Absent | Absent | Negative | Positive | Positive | Negative | 43.8 | Positive | null | Resection | No - suboptimal | 13 | moderate_burden |
PATH-GHA-2024-04067 | Ghana | 2,024 | Regional | Breast | 8140/3 | Adenocarcinoma | Poorly differentiated | Not documented | Not documented | Negative | Negative | Negative | Positive | Not done | Positive | Luminal A | Excisional biopsy | Yes | 4 | moderate_burden |
PATH-KEN-2022-04068 | Kenya | 2,022 | National referral | Stomach | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Positive | Negative | 37.1 | Positive | null | Excisional biopsy | No - suboptimal | 14 | moderate_burden |
PATH-UGA-2023-04069 | Uganda | 2,023 | District | Bladder | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Absent | Negative | Negative | Negative | Negative | Not done | Negative | null | Resection | Yes | 23 | moderate_burden |
PATH-KEN-2018-04070 | Kenya | 2,018 | District | Bladder | 8500/3 | Ductal carcinoma | Moderately differentiated | Absent | Present | Negative | Positive | Negative | Positive | Not done | Positive | null | Core needle biopsy | Yes | 4 | moderate_burden |
PATH-UGA-2018-04071 | Uganda | 2,018 | District | Liver | 8430/3 | Mucoepidermoid carcinoma | Undifferentiated | Present | Present | Negative | Positive | Negative | Negative | 14.3 | Negative | null | Excisional biopsy | Yes | 27 | moderate_burden |
PATH-TAN-2018-04072 | Tanzania | 2,018 | District | Bladder | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Absent | Positive | Positive | Positive | Not done | Not done | Positive | null | Excisional biopsy | Yes | 8 | moderate_burden |
PATH-GHA-2021-04073 | Ghana | 2,021 | National referral | Colorectal | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Present | Negative | Positive | Negative | Negative | Not done | Positive | null | Core needle biopsy | Yes | 9 | moderate_burden |
PATH-UGA-2018-04074 | Uganda | 2,018 | Regional | Thyroid | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Not documented | Negative | Positive | Positive | Negative | 11.2 | Positive | null | Fine needle aspirate | Yes | 21 | moderate_burden |
PATH-GHA-2023-04075 | Ghana | 2,023 | National referral | Cervix | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Present | Negative | Negative | Negative | Negative | Not done | Negative | null | Core needle biopsy | Yes | 24 | moderate_burden |
PATH-TAN-2021-04076 | Tanzania | 2,021 | District | Colorectal | 8140/3 | Adenocarcinoma | Undifferentiated | Absent | Not documented | Close | Positive | Positive | Negative | Not done | Negative | null | Resection | Yes | 18 | moderate_burden |
PATH-SOU-2022-04077 | South Africa | 2,022 | District | Ovary | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Present | Negative | Positive | Negative | Negative | Not done | Negative | null | Core needle biopsy | Yes | 5 | moderate_burden |
PATH-UGA-2018-04078 | Uganda | 2,018 | Regional | Cervix | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Not documented | Present | Negative | Positive | Positive | Negative | 29.7 | Positive | null | Core needle biopsy | No - inconclusive | 26 | moderate_burden |
PATH-TAN-2024-04079 | Tanzania | 2,024 | District | Stomach | 8140/3 | Adenocarcinoma | Well differentiated | Absent | Present | Negative | Positive | Positive | Negative | Not done | Positive | null | Core needle biopsy | Yes | 18 | moderate_burden |
PATH-UGA-2021-04080 | Uganda | 2,021 | Regional | Ovary | 8070/3 | Squamous cell carcinoma | Undifferentiated | Present | Absent | Not applicable | Negative | Not done | Positive | Not done | Negative | null | Core needle biopsy | Yes | 7 | moderate_burden |
PATH-UGA-2024-04081 | Uganda | 2,024 | Regional | Bladder | 8070/3 | Squamous cell carcinoma | Undifferentiated | Not documented | Absent | Negative | Negative | Positive | Negative | Not done | Positive | null | Excisional biopsy | Yes | 27 | moderate_burden |
PATH-UGA-2024-04082 | Uganda | 2,024 | District | Liver | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Present | Not documented | Negative | Negative | Not done | Negative | Not done | Positive | null | Core needle biopsy | Yes | 24 | moderate_burden |
PATH-ETH-2025-04083 | Ethiopia | 2,025 | Regional | Ovary | 8510/3 | Medullary carcinoma | Moderately differentiated | Absent | Absent | Negative | Negative | Not done | Positive | Not done | Positive | null | Resection | Yes | 23 | moderate_burden |
PATH-NIG-2018-04084 | Nigeria | 2,018 | Regional | Prostate | 8430/3 | Mucoepidermoid carcinoma | Poorly differentiated | Absent | Absent | Positive | Positive | Negative | Negative | 74.5 | Negative | null | Core needle biopsy | Yes | 25 | moderate_burden |
PATH-GHA-2022-04085 | Ghana | 2,022 | District | Bladder | 8500/3 | Ductal carcinoma | Poorly differentiated | Present | Absent | Negative | Positive | Positive | Negative | Not done | Positive | null | Excisional biopsy | Yes | 24 | moderate_burden |
PATH-KEN-2018-04086 | Kenya | 2,018 | National referral | Lung | 8310/3 | Clear cell carcinoma | Undifferentiated | Present | Absent | Negative | Positive | Negative | Negative | 70.9 | Negative | null | Excisional biopsy | Yes | 19 | moderate_burden |
PATH-GHA-2024-04087 | Ghana | 2,024 | Regional | Ovary | 8140/3 | Adenocarcinoma | Poorly differentiated | Not documented | Absent | Negative | Positive | Positive | Negative | Not done | Negative | null | Core needle biopsy | Yes | 27 | moderate_burden |
PATH-ETH-2025-04088 | Ethiopia | 2,025 | National referral | Liver | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Present | Negative | Positive | Positive | Negative | 14.6 | Negative | null | Resection | Yes | 24 | moderate_burden |
PATH-TAN-2022-04089 | Tanzania | 2,022 | Regional | Ovary | 8310/3 | Clear cell carcinoma | Poorly differentiated | Absent | Not documented | Close | Positive | Not done | Negative | Not done | Positive | null | Core needle biopsy | Yes | 11 | moderate_burden |
PATH-NIG-2018-04090 | Nigeria | 2,018 | Regional | Colorectal | 8140/3 | Adenocarcinoma | Well differentiated | Absent | Not documented | Close | Negative | Positive | Negative | 67.6 | Positive | null | Core needle biopsy | Yes | 15 | moderate_burden |
PATH-SOU-2019-04091 | South Africa | 2,019 | Regional | Prostate | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Present | Close | Negative | Negative | Negative | 9.1 | Negative | null | Excisional biopsy | Yes | 14 | moderate_burden |
PATH-ETH-2019-04092 | Ethiopia | 2,019 | National referral | Thyroid | 8510/3 | Medullary carcinoma | Undifferentiated | Present | Absent | Positive | Positive | Positive | Negative | 60.1 | Negative | null | Resection | Yes | 9 | moderate_burden |
PATH-SOU-2022-04093 | South Africa | 2,022 | District | Ovary | 8890/3 | Leiomyosarcoma | Poorly differentiated | Absent | Not documented | Negative | Negative | Negative | Negative | Not done | Positive | null | Resection | Yes | 3 | moderate_burden |
PATH-NIG-2024-04094 | Nigeria | 2,024 | District | Lung | 8070/3 | Squamous cell carcinoma | Undifferentiated | Absent | Present | Positive | Positive | Negative | Negative | Not done | Negative | null | Core needle biopsy | No - inconclusive | 6 | moderate_burden |
PATH-NIG-2023-04095 | Nigeria | 2,023 | National referral | Colorectal | 8510/3 | Medullary carcinoma | Poorly differentiated | Absent | Not documented | Negative | Negative | Negative | Negative | 65.3 | Negative | null | Fine needle aspirate | Yes | 17 | moderate_burden |
PATH-GHA-2018-04096 | Ghana | 2,018 | National referral | Stomach | 8890/3 | Leiomyosarcoma | Poorly differentiated | Not documented | Absent | Close | Positive | Not done | Negative | 82.6 | Negative | null | Excisional biopsy | Yes | 10 | moderate_burden |
PATH-SOU-2020-04097 | South Africa | 2,020 | District | Cervix | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Present | Negative | Negative | Negative | Not done | 14.8 | Negative | null | Resection | Yes | 9 | moderate_burden |
PATH-KEN-2024-04098 | Kenya | 2,024 | District | Bladder | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Absent | Negative | Positive | Positive | Negative | Not done | Positive | null | Core needle biopsy | Yes | 14 | moderate_burden |
PATH-NIG-2022-04099 | Nigeria | 2,022 | Regional | Breast | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Not documented | Negative | Positive | Negative | Not done | 47.2 | Positive | Luminal A | Core needle biopsy | Yes | 5 | moderate_burden |
PATH-NIG-2023-04100 | Nigeria | 2,023 | District | Ovary | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Present | Close | Negative | Positive | Not done | 56.5 | Positive | null | Excisional biopsy | Yes | 18 | moderate_burden |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.